Where is the live CopyMark page for USPTO serial 79037302?

The live record is at https://getcopymark.com/trademark/79037302. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns BUSCO-GASTRIC?

According to the public USPTO record for serial number 79037302, the listed owner(s) include: Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharma GmbH & Co. KG.

What is USPTO serial number 79037302?

Serial number 79037302 is the USPTO application identifier for the mark BUSCO-GASTRIC. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover BUSCO-GASTRIC?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: BUSCO-GASTRIC Serial# 79037302 | status 404; last event DENC | Trademark Info & Attorney Guidance

Q: What is the current status of BUSCO-GASTRIC?

BUSCO-GASTRIC (79037302) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BUSCO-GASTRIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ostrolenk, Faber, Gerb & Soffen, LLP

Marin J. Beran, OSTROLENK, FABER, GERB & SOFFEN, LLP1180 Avenue of the AmericasNEW YORK, NY 10036UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations and substances for the treatment of diseases and disorders of the alimentary tract and metabolism, blood and blood forming organs, the cardiovascular system, the musculoskeletal system, the central nervous system, the peripheral nervous system, the genitourinary system, the respiratory system, and dermatological disorders; hormones for medical purposes; anti-infective preparations; anti-viral preparations; cytostatic preparations for use in the treatment of cancer	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 29, 2017	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Sep 29, 2017	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Aug 28, 2015	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Aug 10, 2015	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Aug 10, 2015	INPC	INVALIDATION PROCESSED	—
May 26, 2015	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Sep 26, 2014	C71T	CANCELLED SECTION 71	—
Sep 25, 2009	CHLD	CHANGE OF OWNER RECEIVED FROM IB	—
Jun 6, 2008	FINV	FINAL DECISION TRANSACTION PROCESSED BY IB	—
May 20, 2008	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
May 20, 2008	FIMP	FINAL DISPOSITION PROCESSED	—
May 19, 2008	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Feb 19, 2008	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 4, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 14, 2007	NPUB	NOTICE OF PUBLICATION	—
Oct 31, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Oct 31, 2007	ALIE	ASSIGNED TO LIE	—
Oct 30, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Oct 26, 2007	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Oct 26, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Oct 25, 2007	ALIE	ASSIGNED TO LIE	—
Sep 17, 2007	MAIL	PAPER RECEIVED	—
Jul 13, 2007	RFNT	REFUSAL PROCESSED BY IB	—
Jun 25, 2007	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jun 25, 2007	RFRR	REFUSAL PROCESSED BY MPU	—
Jun 23, 2007	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jun 22, 2007	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2007	RFWR	NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW	—
Jun 5, 2007	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Jun 4, 2007	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2007	DOCK	ASSIGNED TO EXAMINER	—
May 29, 2007	LIMI	LIMITATION FROM ORIGINAL APPLICATION ENTERED	—
May 25, 2007	NWAP	NEW APPLICATION ENTERED	—
May 24, 2007	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

BUSCO-GASTRIC